BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 11205557)

  • 1. [Neuropsychological evaluation of the cognitive deficits in infection by human immunodeficiency virus type 1 (HIV-1)].
    Clemente-Millana L; Portellano JA
    Rev Neurol; 2000 Dec 16-31; 31(12):1192-201. PubMed ID: 11205557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates.
    Goodkin K; Wilkie FL; Concha M; Asthana D; Shapshak P; Douyon R; Fujimura RK; LoPiccolo C
    Neuroimaging Clin N Am; 1997 Aug; 7(3):561-79. PubMed ID: 9376968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV Dementia Scale: predictive power in mild dementia and HAART.
    Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
    J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological impairment-associated visual field deficits in HIV infection. HNRC Group. HIV Neurobehavioral Research Center.
    Plummer DJ; Marcotte TD; Sample PA; Wolfson T; Heaton RK; Grant I; Freeman WR
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):435-42. PubMed ID: 9950603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery.
    Cysique LA; Maruff P; Darby D; Brew BJ
    Arch Clin Neuropsychol; 2006 Feb; 21(2):185-94. PubMed ID: 16343841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV-1 cognitive and motor syndrome].
    Mussa M; Preux PM; Debrock C; Chazot-Balcon M; Melaku Z; Druet-Cabanac M; Kayembe K; Dumas M
    Sante; 1997; 7(3):187-93. PubMed ID: 9296810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropsychological impairment in human immunodeficiency virus-positive children].
    Millana-Cuevas LC; Portellano JA; Martinez-Arias R
    Rev Neurol; 2007 Mar 16-31; 44(6):366-74. PubMed ID: 17385174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of neurological and cognitive changes in patients in stage III and initial phases of stage IV of infection by human immunodeficiency virus type 1].
    Abós J; Graus F; Marqués G; Alom J; Miró JM; Mallolas J; Tolosa E
    Med Clin (Barc); 1992 Jan; 98(2):41-4. PubMed ID: 1545618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropsychological changes in drug addicts infected with human immunodeficiency virus].
    Sopelana P; Débora M; López-Calvo S; García-Alvarez JC; Polo C
    Arch Neurobiol (Madr); 1992; 55(5):228-34. PubMed ID: 1482276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.
    Vitiello B; Goodkin K; Ashtana D; Shapshak P; Atkinson JH; Heseltine PN; Eaton E; Heaton R; Lyman WD
    AIDS; 2007 Jul; 21(11):1415-22. PubMed ID: 17589187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of human immunodeficiency virus-associated neocortical damage.
    Masliah E; Achim CL; Ge N; DeTeresa R; Terry RD; Wiley CA
    Ann Neurol; 1992 Sep; 32(3):321-9. PubMed ID: 1416802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive slowing in asymptomatic individuals who are seropositive for human immunodeficiency virus type 1].
    Amador F; Mayor-Ríos J; del Castillo-Martín N
    Rev Neurol; 2006 Feb 1-15; 42(3):132-6. PubMed ID: 16475133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluations in HIV-1-associated cognitive/motor complex.
    Syndulko K; Singer EJ; Nogales-Gaete J; Conrad A; Schmid P; Tourtellotte WW
    Psychiatr Clin North Am; 1994 Mar; 17(1):91-123. PubMed ID: 8190671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological impairment and the natural history of HIV-1 infection in Spanish subjects.
    Rodríguez Alvarez M; Faílde Garrido JM; Simón López MA
    Funct Neurol; 2007; 22(3):165-70. PubMed ID: 17925167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dementia and human inmmunodeficiency virus infection].
    Gray F
    Rev Neurol (Paris); 1998; 154 Suppl 2():S91-8. PubMed ID: 9834549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of coinfection with HIV and hepatitis C virus on the nervous system.
    Aronow HA; Weston AJ; Pezeshki BB; Lazarus TS
    AIDS Read; 2008 Jan; 18(1):43-8. PubMed ID: 18240452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive outcomes in pediatric HIV.
    Willen EJ
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):223-8. PubMed ID: 17061290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.